CivicKnodeCivicKnowA project of CivicKnode
Sign in

HB 663

Enacted
Add to calendar

Prescription Drug Monitoring Program - Out-of-State Pharmacists and Discipline for Noncompliance

Sponsor: Chair, Health and Government Operations CommitteeCommittee: Health and Government OperationsSubject: Public HealthStatus: Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 290 (as of Nov 6, 2020)

What this bill does

Official synopsis

Altering the definition of the term 'pharmacist' in provisions of law regarding the Prescription Drug Monitoring Program to include pharmacists licensed in other states to dispense monitored prescription drugs; and altering the grounds for which a certain health occupations board and certain disciplinary panels are authorized to take disciplinary action against certain licensees and applicants for failing to comply with the requirements of the Program.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (7)

MGA witness list
FAV 7Favorable
PositionWitnessOrganizationTestimony
FAVHawk, WyneeBoard of PhysiciansOral
FAVYe, WebsterMD Dept of HealthWritten (PDF)
FAVKasemeyer, PamMedChiPosition only
FAVJackson, Katedept of healthPosition only
FAVWhitaker, Jakelobbyistdept of healthOral + Written (PDF)
FAVChair, Health and Government Operations Committee, Chair, Health and Government Operations CommitteeIndividualPosition only
FAVChair, Health and Government Operations Committee, Chair, Health and Government Operations CommitteeIndividualPosition only

Organizations on record

Registered lobbyists who testified

FAVWhitaker, Jakedept of healthRegistered for: Maryland Hospital Association